Russia’s Gamaleya Institute, which developed the Sputnik V coronavirus vaccine, has applied for emergency use authorization in the Philippines.
The Moscow-based company filed its application on Thursday, according to the Philippines News Agency.
A day before that, Gamaleya withdrew its application to hold clinical trials in the country, according to CNN affiliate CNN Philippines.
Gamaleya is the third vaccine maker — alongside Pfizer-BioNTech and Oxford-AstraZeneca — to apply for emergency use authorization in the Philippines.
It usually takes the Philippines’ Food and Drug Administration 21 days to decide if a drug or vaccine will be allowed for use in the country, according to CNN Philippines.
Last November, Russia said the Sputnik V vaccine was at least 91.4% effective and could be more than 95% effective, according to data from its Phase 3 trials.
You may also like
-
UK coronavirus variant has been reported in 86 countries, WHO says
-
NASA technology can help save whale sharks says Australian marine biologist and ECOCEAN founder, Brad Norman
-
California Twentynine Palms: Explosives are missing from the nation’s largest Marine Corps base and an investigation is underway
-
Trump unhappy with his impeachment attorney’s performance, sources say
-
Lunar New Year 2021: Ushering in the Year of the Ox